Sponsor Pipeline

Novatim Immune Therapeutics (Zhejiang) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06928363 A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. Solid Tumors Not Yet Recruiting
Phase 1
NCT06518876 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS… POEMS Syndrome Not Yet Recruiting
Get alerts when Novatim Immune Therapeutics (Zhejiang) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free